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α-Synuclein is a 140 residue protein associated with Parkinson’s disease and other
neurodegenerative disorders.[1,2] The protein has three distinct regions. The N-terminal
region is positively charged; the hydrophobic core [also known as the non-amyloid
component (NAC)] comprises residues 61–90, and the C-terminal region is negatively
charged. Its filamentous inclusions are found in dementia with Lewy bodies and multiple
system atrophy.[3] α-Synuclein aggregates formed in vitro near physiological pH are
morphologically indistinguishable from those in Lewy bodies.[4] Understanding α-
synuclein’s fibrillation mechanism at the molecular level is key to discovering or designing
drugs to slow, prevent, or even reverse its aggregation.[5]
At low sodium dodecyl sulfate (SDS) concentrations (<~2 mM), α-synuclein assembles into
highly ordered amyloid fibrils.[6–9] At high SDS concentrations (>~20 mM), monomeric α-
synuclein forms two stable anti-parallel curved α-helices followed by an unstructured tail.
[10–17] How α-synuclein switches from an unfolded monomer in buffer to a helical
conformation in SDS and why SDS promotes aggregation remain unclear. Here, we identify
the conformational state through which amyloid fibril formation most likely occurs by using
highly sensitive 19F NMR spectroscopy and site specifically labeled a-synuclein to probe the
conformational switch.
First, we used two dimensional 1H-15N Heteronuclear Single Quantum Correlation (HSQC)
spectra to monitor conformational changes in 100 µM α-synuclein upon increasing the SDS
concentration from 0.8 mM to 24 mM at 25 °C (Figure 1). No aggregation occurred during
the 20 min NMR experiments. As observed previously,[9,18] resonances from residues in
the C-terminal region remain unchanged, but the resonances from residues in the N-terminal
region are broadened beyond detection in 0.8 and 2.4 mM SDS. The line broadening could
arise from chemical exchange between the free and micelle-bound states occurring at rates
approximating the difference in resonance frequencies in the two environments.[8,9] In 24
mM SDS, additional new resonances appear, but they are broad compared to the relatively
sharp resonances from the C-terminal residues.
The 19F chemical shift is sensitive to local environment and it is widely used to monitor
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four variants of α-synuclein by substituting the unnatural amino acid L-4-
trifluoromethylphenylalanine (tfmF) at phenylalanine 4, tyrosine 39, valine 70 and tyrosine
133. These positions were chosen to provide a probe in each of the three regions descibed
above. Residues 4 and 39 are present in the N-terminal region, residue 70 is in the NAC-
region, and residue 133 is in the C-terminal region. We chose these particular residue types
because their aromatic or bulky hydrophobic side chains are similar.
One-dimensional 19F NMR spectra were recorded in the absence and in the presence of 0.8,
2.4 and 24 mM SDS (Figure 2). The conditions and the molar ratio of protein to SDS were
kept the same as those used to obtain the HSQC data.
Without SDS, the 19F resonances from tfmF labeled proteins are sharp and show little
chemical shift dispersion, as expected for a disordered protein. A sharp transition (~0.5 ppm
shift) for the F4tfmF resonance takes place at 0.8 mM SDS, while the transitions for the
Y39tfmF (~0.6 ppm shift) and V70tfmF (~1.2 ppm shift) resonances take place at 2.4 mM
SDS. Y133tfmF does not exhibit any change from 0 to 24 mM SDS. Many studies show that
α-synuclein adopts α-helical structure in SDS.8–11 Our data pinpoint the location of the
changes at the residue level. Such information is unavailable from methods such as circular
dichrosim (CD) and fluorescence spectroscopies. Another feature of the 19F spectra is that
the resonances are broad in SDS solution compared to dilute solution, except for Y133tfmF.
The results from light scattering experiments show that the broadness is not due to the
formation of large soluble oligomers in SDS.[7] Instead, the broadness is caused by
conformational exchange in the ensemble. These resonances sharpen when the SDS
concentration is increased from 0.8 to 24 mM, indicating a dynamic interaction between α-
synuclein and SDS.
Ahmad et al.[7] found that SDS promotes α-synuclein fibril growth at an optimal
concentration range of 0.5–0.75 mM. At these SDS concentrations, the α-synuclein
ensemble shows enhanced amounts of hydrophobic surface. When the SDS concentration is
above 2 mM, less- or non-fibrillogenic ensembles form. These ensembles are characterized
by less hydrophobic surface and maximum helix content. Our data are consistent with these
conclusions and others derived from isothermal titration calorimetry (ITC), CD
spectroscopy, hydrophobic dye binding, and fluorescence lifetime data.[7,31,32] Due to the
site specific labeling, our 19F data provide detailed conformational switch information
unobtainable from other techniques.
Figure 3 describes the SDS-induced conformational switch. In dilute solution, α-synuclein is
disordered. CD data indicate that α-synuclein acquires α-helical switch in SDS solution.
[7,9] Changes in chemical shift from 0.8 to 2.4 mM SDS, indicate that the partial helical
conformation is induced in the first several residues, including F4tfmF. But the small shift
change indicates that residues after Y39tfmF remain disordered. This partial helical
conformation is probably responsible for the fast aggregation of α-synuclein.
Above 2.4 mM SDS, a more folded α-synuclein with a higher helix-content forms[12] as
indicated by the changes in chemical sift observed for the V70tfM protein. The C-terminal
region of this species, as monitored at position 133, remains disordered. This species is
known to be less aggregation prone and fully micelle bound. These conformations exchange
on the ~ms time scale based on the difference in 19F chemical shift between the states. The
intensity increase and lack of chemical shift change with increasing SDS concentration
indicates both dynamic changes and structural homogeneity.
α-Synuclein function is suggested to be related to membrane binding.[2,33–36] SDS
micelles are often used to mimic the membrane environment. Recent data from NMR
studies of α-synuclein-membrane binding suggest that the N-terminus (residues 3–25) binds
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membranes as a helix, while the hydrophobic non-amyloid component region remains
dynamically disordered.[37,38] This bound state is prone to intermolecular interactions that
progress toward disease-associated oligomers and fibrils. Our proposed aggregation prone
state is consistent with the membrane bound state. Single-molecule fluorescence resonance
energy transfer experiments have also been employed to investigate SDS induced species.
[10,39] These studies suggests that α-synuclein adopts a metastable structure. Our 19F data
provide direct evidence that this metastable, aggregation prone state exists in a membrane
mimetic environment.
Previously, we used 19F NMR to examine the conformational change of α-synuclein by
using 3 fluorotyrosine (3FY) labeling.[8] We showed that 19F NMR is a good probe of
conformational change at the level of individual residues.[8] tfmF labeling offers at least
five advantages compared to 3FY. First, assignment is not required. Second, we obtain
higher sensitivity because tfmF contains three times the 19F. Third, tfmF has advantageous
NMR relaxation properties. Fourth, any single ribosomally encoded amino acid can be
replaced with tfmF. Fifth, 19F NMR of tfmF labeling can also be applied to study large
proteins or protein complexes (to 100 kDa), which is challenging for routine solution NMR
spectroscopy.[40,41] It must be borne in mind, however, that the trifluromethyl group may
affect protein properties. Protein conformational switching is a general mechanism in signal
transduction. Here, we describe a powerful and easy 19F NMR method to assess switching
phenomena.
Experimental Section
The protein was labeled and expressed by using an orthogonal tRNA/tRNA synthase system.
[40] Briefly, stop codons (TAG) were incorporated in the arabinose-inducible expression
vector pBAD at the sites for labeling by using site-directed mutagenesis (QuickChange,
Stratagene). The mutations were confirmed by DNA sequencing. A single DH10B colony
from an ampicillin/tetracycline plate containing both the appropriate pBAD and pDule-tfm-
Phe vectors was picked and used to inoculate 50 mL of LB media (containing 100 mg/L
ampicillin and 25 mg/L tetracycline). The culture was grown overnight at 37 °C with
shaking at 250 rpm. An aliquot (2.5 mL) was added to warm arabinose autoinduction
medium (500 mL). tfmF was added after 30 min (1 mM final concentration) from a stock
solution (100 mM) prepared by dissolution in NaOH (20 mM). This culture was grown for
an additional 40 h (absorbance at 600 nm of ~5). Cultures were centrifuged at 1 200g for 30
min at room temperature. The cell pellets were resuspended in lysis buffer (20 mL, 10 mM
Tris, pH 8.0, 1 mM EDTA, 1 mM PMSF), sonicated (FisherScientific, Sonic Dismembrator
Model 500) on ice for 5 min with a duty cycle of 1 s on, 2 s off. The sonicated sample was
boiled for 20 min (to precipitate globular proteins) and then centrifuged at 16 000g for 30
min. Nucleic acids were precipitated with streptomycin sulfate (10 mg/mL, 4 °C, 30 min)
and removed by centrifugation (16 000g, 30 min). Proteins were precipitated with
(NH4)2SO4 (360 g/L, 4 °C, 30 min). The pellet was collected by centrifugation (16 000g, 30
min) and resuspended in low salt buffer (20 mL, 20 mM Tris, pH 7.7). Protein in low salt
buffer was then loaded onto HiLoad 16/10 Q Sepharose High Performance column (GE
Healthcare) in Tris (20 mM), pH 7.7 and eluted with in a NaCl gradient (0 – 1 M) over 160
min (α-synuclein elutes at ~300 mM). Fractions containing α-synuclein (analyzed by
Coomassiestained SDS–PAGE) were concentrated with a 5K MWCO filter (Millipore,
Bedford, Massachusetts), loaded onto a Supedex™ 75 column (GE Healthcare) and eluted
(150 mM NaCl, 20 mM Tris, pH 8.0). Fractions containing α-synuclein were combined and
lyophilized. Purity was assessed by using SDS-PAGE. The identity of the proteins was
confirmed by using mass spectrometry (NanoESI-MS).
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19F NMR spectra were acquired on an INOVA 600 MHz spectrometer equipped
with 19F(1H) probes at 25 °C. The 19F spectra comprised 512 transients, a 30 kHz sweep
width, with a 2 s delay between transients. 19F chemical shifts are referenced to
trifluoroethanol at 0 ppm. All spectra were acquired under similar conditions.
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HSQC spectra of 100 µM uniformly 15N enriched α-synuclein in A, 0 mM; B, 0.8 mM, C,
2.4 mM, and D, 24 mM SDS. Samples are prepared in 50 mM sodium phosphate buffer (pH
7.4). Spectra were acquired on an INOVA 600 MHz spectrometer equipped with a HCN
triple resonance probe at 25 °C. Several Resonances from C-terminal residues [9.18] are
circled and labelled individually.
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19F NMR spectra of labeled 100 µM α-synucleins with tfmF residue at position 4, 39, 70
and 133 in 0, 0.8, 2.4 and 24 mM SDS. The residues mutated to tfmF are indicated at the top
of each spectrum. Samples are prepared in 50 mM sodium phosphate buffer (pH 7.4). The
apparent lower signal-to-noise ratio of some spectra is the result of expanding the y-axis to
facilitate observation of broad, low-sensitivity resonances.
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Illustration of the conformational switch induced by SDS. Dots represent the tfmF sites. The
thick lines represent α-helices.
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